Ariad Pharmaceuticals Inc fka ARIA

[BTH]

Any chance he can share more than what we know about the 2nd interim?

Answer: probably not likely.

I am not sure if either Merck or Ariad is allowed to see the results. Likely has to be written as part of the SPA.

Dendreon was allowed to look at their interim numbers (which essentially made investing in the company a layup considering the interim numbers showed positive efficacy).

FDA are crooks, IMO.

I would be SHOCKED if the FDA made Ariad go through a full trial (12 - 18 months) for '534. The drug CLEARLY works, and it would be criminal not to let patients have the drug. I truly believe this is another aspect of partnering: you need big partners because they have high influence in cutting through the bogus garbage the FDA pawns down on many small biotechs (without influence).